ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and ...
All International Development and Education Award (IDEA) applications are carefully reviewed and evaluated by the IDEA Steering Group. The Steering Group scores and ranks the applications using ...
First authors should submit their poster and optional materials (slides, video recordings, etc.) to ASCO's Speaker Center by June 8, 2026. For security reasons, presentation slides cannot be submitted ...
Couldn’t attend #ASCOBT26? See a little of what you missed with curated videos from last year’s program, and join us next year in Singapore! Scroll down to see all videos. Videos are expandable to ...
We want you to have the best meeting experience possible. In order to help you navigate through the meeting and get the most out of the content, we have prepared the below. ASCO Breakthrough is ...
Posters and slides will be available to registered attendees at the scheduled session start time. Please refer to meetings.asco.org for more session details. A ...
For people with inflammatory bowel disease, GLP-1 receptor agonists may lower colorectal cancer risk
Inflammatory bowel disease (IBD) is a group of conditions that cause inflammation and swelling in the digestive tract. The most common types of IBD are Crohn’s disease and ulcerative colitis. Type 2 ...
Cancer caused nearly 10 million deaths worldwide in 2020, and 70% of those deaths occurred in low- and middle-income countries. Most of the countries where this study took place have national ...
Please find information below about 2026 ASCO Breakthrough. If you are a public relations professional looking for meeting information, please see our For PR Professionals page. ASCO's Media ...
ASCO's Leadership Development Program (LDP) in Central and Eastern Europe identifies and prepares leaders in oncology with essential skills to make a lasting impact within institutions, across the ...
Investigators studied the health records of more than 12,000 people with 7 types of cancer to see how 2 common types of diabetes medicines affect the spread of the disease. This real-world data shows ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results